Table 2 Distribution of clinical tumor stage compared with postchemoradiation pathologic stage.
Clinical staging | Postchemoradiotherapy pathologic (yp) staging | Total (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
ypT0N0 | ypT1N0 | ypT1N1 | ypT2N0 | ypT2N1 | ypT3N0 | ypT3N1 | ypT4N0 | ypT4N1 | ||
c T3 N0 | 4 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 (11.6) |
c T3 N1 | 0 | 4 | 6 | 0 | 3 | 0 | 2 | 0 | 0 | 15 (34.9) |
c T4 N0 | 0 | 0 | 0 | 5 | 0 | 3 | 0 | 5 | 0 | 13 (30.2) |
c T4 N1 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 0 | 4 | 10 (23.3) |
Total (%) | 4 (9.3) | 5 (11.6) | 6 (14) | 5 (11.6) | 3 (7) | 3 (7) | 8 (18.6) | 5 (11.6) | 4 (9.3) | 43 (100) |